The global disposable insulin-delivery device market is projected to experience robust growth over the next decade, according to recent industry insights. Valued at USD 14,585.6 million in 2022, the ...

The NovoPen Echo smart insulin pen now works with Dexcom CGM ... In addition to improving HbA1c, Omnipod 5 users spent an additional 5.4 hours per day in target glucose range compared to MDI. This ...

By seamlessly integrating Dexcom CGM data with NovoPen® 6 and NovoPen Echo® Plus insulin data in one app, healthcare professionals gain a comprehensive, actionable view of a patient’s glucose ...

The NovoPen Echo smart insulin pen now works with Dexcom CGM. [Image from Novo Nordisk] Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous ...